SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Dr Lalchandani Labs Ltd

BSE: 541299 NSE: ISIN: INE871Z01013
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Dr Lalchandani Labs Ltd belong to?
Dr Lalchandani Labs Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Dr Lalchandani Labs Ltd a good quality company?
Dr Lalchandani Labs Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Dr Lalchandani Labs Ltd undervalued or overvalued?
Dr Lalchandani Labs Ltd appears Somewhat Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Dr Lalchandani Labs Ltd a good buy now?
Dr Lalchandani Labs Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd revenue growth is -7.5% for FY-2025 , which is below its 5 year CAGR of -6.1% , indicating slower growth.
Q.2 Gross Profit margin of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd Gross profit margin which is the profit after deduction of direct costs, is 19% for FY-2025 , which is above its 5 year median of 16.6% , indicating increasing margins.
Q.3 Operating Profit Margin of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 20.76% for FY-2025 , which is in line with its 5 year median of 20.76% indicating stable margins.
Q.4 Net Profit Margin of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd Net Profit Margin is 9.37% for FY-2025 , is in line with with its 5 year median of 9.37%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 19 16.6
Operating Profit Margin 20.76 20.76
Net Profit Margin 9.37 9.37
Q.5 Return on Asset of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd Return on Asset is 2.71%, which is below its 5 year historical median of 3.78%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd Return on equity is 4.29% for FY-2025 , which is below its historical median of 6.7%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd Return on capital employed is 3.61% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd Cash conversion cycle is 393 days, above its historical median of 312 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.29 0.29
ROE 4.29 6.7
ROCE 3.61 7.07
Cash Conversion Cycle 393 days 312 days
Q.9 Debt to Equity ratio of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd Debt-to-Equity ratio is 0.41 , which is above with the industry average of 0.22 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd Debt to cash flow from operations is 11.08 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Dr Lalchandani Labs Ltd?
Promoters hold 32.90% of the Dr Lalchandani Labs Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Dr Lalchandani Labs Ltd vs industry peers?
Dr Lalchandani Labs Ltd revenue CAGR is -6.11% , compared to the industry median CAGR of 1.49% , indicating stable growth and maintaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 4.5 144
Gross Profit 0.9 8.2
Operating Profit 0.9 8.4
Net Profit 0.4 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.29 0.73
ROE 4.29 13.88
ROCE 3.61 17.77
Cash Conversion Cycle (days) 392.74 2

Valuation & price assessment

Q.1 Stock return of Dr Lalchandani Labs Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -12.45% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - -12.5% -23% 4.6%
Q.3 Valuation ratios of Dr Lalchandani Labs Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 20.06 12.07 79.71
Price to Book 0.59 1.09 3.54
Price to Sales 1.88 1.00 4.37
EV to EBITDA 9.82 5.21 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Vijaya Diagnostic
8. Metropolis Health.
9. Park Medi World
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×